Age and sex distribution in malignant and tuberculous serous effusions: A study of 127 patients and review of the literature

Das, Dilip K.

doi:10.1111/ggi.12412

Cited by 10 publications

(10 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the study, we found that male sex was a risk factor for TE. A possible explanation for it is that sex imbalance exists in TPEs 27,28 . Das DK et al .…”

Section: Discussionmentioning

confidence: 99%

“…Das DK et al . analyzed the sex distribution of TPE patients included in the previous published literatures, and most of studies (3/20) showed that female patients constituted the majority of TPEs (>50%) 28 . In the United States, from 1993 through 2003, 7,549 cases of pleural TB were reported, males comprised 67% and females 33% of the patient population.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Risk factors for tuberculous empyema in pleural tuberculosis patients

Peng

Wei

Han

et al. 2019

Sci Rep

View full text Add to dashboard Cite

Tuberculous empyema (TE) is associated with high mortality and morbidity. In the retrospective cohort study, we aimed to find risk factors for TE among pleural tuberculosis (TB) patients. Between July 2011 and September 2015, all culture-confirmed pleural TB patients (474 cases) were enrolled in our study. Empyema was defined as grossly purulent pleural fluid. Demographic and epidemiological data were collected for further analysis. Multivariate logistic regression analysis was used to evaluate risk factors of TE in pleural TB, age–adjusted odds ratio (OR) and 95% confidence interval (CI) were calculated to show the risk. The mean age was 35.7 ± 18.1 years old, males comprised 79.1% of the participants (375 cases). Forty-seven patients (9.9%) were multidrug-resistant TB (MDR-TB), 29 (6.1%) had retreatment TB, 26 (5.5%) had diabetes mellitus. The percentage of empyema patients was 8.9% (42 cases). Multivariate analysis revealed that male (adjusted OR = 4.431, 95% CI: 1.411, 13.919), pleural adenosine deaminase (ADA, >88 U/L) (adjusted OR = 3.367, 95% CI: 1.533, 7.395) and white blood cell (WBC, >9.52 109/L) (adjusted OR = 5.763, 95% CI: 2.473, 13.431) were significant risk factors for empyema in pleural TB, while pulmonary TB (adjusted OR = 0.155, 95% CI: 0.072, 0.336) was the protective factor for the patients. TE remains a serious threat to public health in China. Male sex is a significant risk factor for TE while the presence of pulmonary TB is protective, and high levels of pleural ADA and WBC count could aid in early diagnosis of TE. This finding would help towards reducing the mortality and morbidity associated with TE.

show abstract

“…In the study, we found that male sex was a risk factor for TE. A possible explanation for it is that sex imbalance exists in TPEs 27,28 . Das DK et al .…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Risk factors for tuberculous empyema in pleural tuberculosis patients

Peng

Wei

Han

et al. 2019

Sci Rep

View full text Add to dashboard Cite

show abstract

“…20-55% of patients with pulmonary embolism have a pleural effusion. Bintcliffe, et al found that 70% of 126 patients with a pleural effusion did, indeed, have a single cause for it, but 30% had more than one cause [15].…”

Section: Pleural Effusion In Adults-etiology Diagnosis and Treatmentmentioning

confidence: 99%

Etiology of Pleural Effusion among Adults in Three University Hospitals in Beirut: A One-Year Retrospective Cross Sectional Analytical Study

Ali¹,

Amrou²,

Ibrahim³

2021

Int J Respir Pulm Med

View full text Add to dashboard Cite

Background: Pleural effusion, the pathological accumulation of fluid in the pleural space, is very common. It has a wide differential diagnosis, and a delayed etiological diagnosis can be associated with markedly higher morbidity and mortality. It is divided into two main types: Transudative and Exudative, depending on the mechanism of fluid accumulation. The most common causes of pleural effusion are: Congestive heart failure, infections, malignancy, liver and kidney failure. Thoracentesis may be indicated as a therapeutic procedure to relieve symptoms or as a diagnostic procedure by analyzing the pleural fluid using Light's criteria which differentiate Transudative from Exudative effusions. The main objective of this study is to determine the prevalence and etiologies of different types of pleural effusion, and to assess its relation with some potential risk factors.Methods: This is a one-year retrospective cross-sectional analytical study. We collected data from 131 patients who underwent thoracentesis at the Lebanese Hospital Geitawi,

show abstract

“…29 (61,7%) pacijenata je pripadalo grupi ≥50 godina, dok je 18 (38,3%) pripadalo grupi ≥60 godina. Zaključak njegovog istraživanja je da se maligni pleuralni izlivi češće javljaju kod starijih i osoba srednjih godina i da su češći kod žena, a tuberkulozni izlivi se javljaju češće kod mlađih osoba [15].…”

Section: Diskusijaunclassified

Palliative pleurocentesis in patients with malignant pleural effusion

Davidović¹,

Veselinov²,

Davidovic³

2016

Tim Med Glas

View full text Add to dashboard Cite

Uvod: Pleurocenteza (torakocenteza) je dijagnostičko-terapijska metoda koja se koristi za dobijanje uzorka ili evakuaciju pleuralne tečnosti. Palijativna pleurocenteza se izvodi u cilju evakuacije malignog izliva koji je znak uznapredovalog stadijuma maligne bolesti. Cilj: Prikazati primenu metode palijativne pleurocenteze i odnos broja pacijenata sa malignim pleuralnim izlivom u zavisnosti od porekla primarnog tumora u jednogodišnjem periodu. Pacijenti i metode: U periodu od 01. 08. 2014. do 01. 08. 2015. godine na hirurškom odeljenju Opšte bolnice u Kikindi primenjena je palijativna pleurocenteza kod 23 pacijenta, prosečne starosti 68,6 godina. Dijagnoza je prethodno postavljena na osnovu kliničkog pregleda i rendgenskog snimka pluća. Za punkciju je korišćen set za jednokratnu upotrebu Pleurofix® Nr.1, kompanije B. Braun. Kod svih pacijenata pleurocenteza je izvedena u sedećem položaju, u lokalnoj anesteziji (2% lidokain), u VII ili VIII međurebarnom prostoru, u zadnjoj aksilarnoj liniji, tik uz gornju ivicu donjeg rebra. Za statističku analizu korišćen je χ 2-test. Rezultati: Palijativna pleurocenteza je primenjena kod 14 (60,87%) žena i 9 (39,13%) muškaraca (χ 2 =1,08; p>0,05). Ukupno je urađeno 38 pleurocenteza, prosečno po pacijentu 1,65. Jedna pleurocenteza je urađena kod 18 (78,25%) pacijenata, a dve ili više kod 5 (21,75%) pacijenata (χ 2 =30,21; p<0,01). Dve pleurocenteze su urađene kod 1 (4,35%), tri kod 2 (8,7%) i šest kod 2 (8,7%) pacijenta. Sa desne strane je urađena kod 14 (60,87%), a sa leve kod 6 (26,09%) pacijenata (χ 2 =8,43; p<0,05). Obostrano je urađena kod 3 (13,04%) pacijenta. Etiološki, karcinom pluća je bio uzrok kod 9 (39,13%), dojke kod 4 (17,39%), GIT-a kod 3 (13,04%), UGT-a kod 3 (13,04%), dok je kod 4 (17,39%) pacijenta ostalo nepoznato mesto primarnog tumora. Zaključak: Maligni pleuralni izliv se najčešće javlja kod pacijenata obolelih od karcinoma pluća i dojke. Češće je lokalizovan na desnoj strani. Kod značajnog broja pacijenata ostaje nepoznato mesto primarnog tumora. Palijativna pleurocenteza ima ulogu u trenutnom ublažavanju simptoma. U cilju adekvatnog tretmana potrebno je konsultovati grudnog hirurga. Ključne reči: Maligni pleuralni izliv; pleurocenteza; torakocenteza.

show abstract

Age and sex distribution in malignant and tuberculous serous effusions: A study of 127 patients and review of the literature

Abstract: Whereas malignancy in serous effusions is found in older and middle-aged people, tuberculous effusion is a disease of younger people.

Cited by 10 publications

References 27 publications

Risk factors for tuberculous empyema in pleural tuberculosis patients

Risk factors for tuberculous empyema in pleural tuberculosis patients

Etiology of Pleural Effusion among Adults in Three University Hospitals in Beirut: A One-Year Retrospective Cross Sectional Analytical Study

Palliative pleurocentesis in patients with malignant pleural effusion

Contact Info

Product

Resources

About